| Firm |
Analyst |
JMP Securities
450 Park Avenue
Suite 1500
New York, NY 10022
|
Charles Duncan |
Leerink Swann & Co.
One Federal Street
37th Floor
Boston, MA 02110
|
Joseph Schwartz |
Morgan Stanley & Co. Inc
1585 Broadway
New York, NY 10036
|
Steven Harr |
Oppenheimer & Co., Inc.
300 Madison Avenue
New York, NY 10017
|
Bret Holley |
Rodman & Renshaw Co., LLC
330 Madison Ave.
27th Floor
New York, NY 10017
|
Reni Benjamin |
WBB Securities, LLC
125 Elm Street
Westfield, NJ 07090
|
Stephen Brozak |
BioCryst Pharmaceuticals Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding BioCryst Pharmaceuticals Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BioCryst Pharmaceuticals Inc. or its management. BioCryst Pharmaceuticals Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
|
|
